MODERATE-TO-SEVERE PLAQUE PSORIASIS
Clinical trials for MODERATE-TO-SEVERE PLAQUE PSORIASIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE-TO-SEVERE PLAQUE PSORIASIS trials appear
Sign up with your email to follow new studies for MODERATE-TO-SEVERE PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists probe psoriasis Drug's effect on skin genes
Disease control Recruiting nowThis study aims to understand how the medication bimekizumab affects specific genes in the skin of people with moderate to severe plaque psoriasis. It will enroll 90 adults, some with psoriasis alone and some who also have psoriatic arthritis. Researchers will take small skin sam…
Matched conditions: MODERATE-TO-SEVERE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New shot for Kids' skin disease enters final testing phase
Disease control Recruiting nowThis study aims to see if a new injectable drug called bimekizumab works better and is as safe as an existing drug, ustekinumab, for children and teenagers with moderate to severe plaque psoriasis. It will involve about 168 participants aged 6 to 18. The main goal is to see if th…
Matched conditions: MODERATE-TO-SEVERE PLAQUE PSORIASIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New pill targets skin disease in 12-Week trial
Disease control Recruiting nowThis study is testing a new oral medication called a TYK2 inhibitor for people with moderate to severe plaque psoriasis. About 140 participants will take either the real pill or a placebo (sugar pill) for 12 weeks to see if it safely reduces skin redness, thickness, and scaling. …
Matched conditions: MODERATE-TO-SEVERE PLAQUE PSORIASIS
Phase: NA • Sponsor: Usynova Pharmaceuticals Ltd. • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Moms on arthritis drug help science understand breastfeeding safety
Knowledge-focused Recruiting nowThis study aims to measure how much of the medication bimekizumab (Bimzelx®) passes into breast milk. It will enroll 20 breastfeeding mothers who are already using this drug to treat conditions like psoriasis or arthritis. Researchers will collect breast milk samples over several…
Matched conditions: MODERATE-TO-SEVERE PLAQUE PSORIASIS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC